Do the FDA’s Proposed Regulations on Tanning Bed Use Go Far Enough?

Posted By American Med Spa Association, Monday, March 21, 2016

As the comment period on the US Food and Drug Administration’s proposal to restrict tanning bed use winds down, researchers are weighing in on the proposal's merits and potential shortfalls. Investigators Elliot J. Coups, PhD, a behavioral scientist at Rutgers Cancer Institute and an associate professor of medicine at Rutgers Robert Wood Johnson Medical School in New Brunswick, NJ, Alan C. Geller, MPH, RN, from Harvard School of Public Health in Boston; and Sherry Pagoto, PhD, from University of Massachusetts Medical School in Worcester, MA, share their thoughts in the current online edition of JAMA Dermatology. Dr. Coups answers some questions about the proposed regulations in a news release. Q: What is the concern with this particular population and tanning bed use? A: Over the past several decades, tanning bed use, particularly among teen girls and young adult women has become a modern-day epidemic. More than 30 percent of non-Hispanic white girls ages 16 and 17 years report indoor tanning at least once in the past year (Guy G.P., et al., JAMA Dermatology, 2015). Indoor tanning increases the risk for developing melanoma (the most lethal type of skin cancer), especially among individuals who start tanning at a young age. Although melanoma is most commonly diagnosed among individuals over 60 years of age, it is the third most common cancer diagnosed among those aged 15 to 39 years (Keegan T.H.M., et al., Cancer, 2016). Read more at DermWire.